Ticker | $ Bought |
---|---|
10x genomics inc-class a | 12,746,300 |
Ticker | % Inc. |
---|---|
quanterix corp | 157 |
personalis inc | 42.62 |
Ticker | % Reduced |
---|---|
guardant health inc | -36.74 |
natera inc | -20.14 |
Blue Water Life Science Advisors, LP has about 100% of it's holdings in Healthcare sector.
Sector | % |
---|---|
Healthcare | 100 |
Blue Water Life Science Advisors, LP has about 22.3% of it's portfolio invested in the large-cap and mega-cap stocks.
Category | % |
---|---|
SMALL-CAP | 36 |
MID-CAP | 28.2 |
LARGE-CAP | 22.3 |
MICRO-CAP | 13.5 |
About 58.9% of the stocks held by Blue Water Life Science Advisors, LP either belong to S&P 500 or RUSSELL 2000 index.
Index | % |
---|---|
RUSSELL 2000 | 58.9 |
Others | 41.1 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Blue Water Life Science Advisors, LP has 8 stocks in it's portfolio. AKYA proved to be the most loss making stock for the portfolio. ADPT was the most profitable stock for Blue Water Life Science Advisors, LP last quarter.
Last Reported on: 14 Aug, 2025Ticker | Namesorted descending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
---|---|---|---|---|---|---|---|---|
NTRA | natera inc | 22.26 | 166,494 | 28,127,500 | reduced | -20.14 | ||
Historical Trend of NATERA INC Position Held By Blue Water Life Science Advisors, LLCWhat % of Portfolio is NTRA?:Number of NTRA shares held:Change in No. of Shares Held: | ||||||||
ADPT | adaptive biotechnologies cor | 19.78 | 2,145,140 | 24,990,900 | unchanged | 0.00 | ||
GH | guardant health inc | 18.09 | 439,047 | 22,848,000 | reduced | -36.74 | ||
CDNA | caredx inc | 11.20 | 724,014 | 14,147,200 | unchanged | 0.00 | ||
TXG | 10x genomics inc-class a | 10.09 | 1,100,720 | 12,746,300 | new | |||
PSNL | personalis inc | 8.70 | 1,676,300 | 10,996,500 | added | 42.62 | ||
QTRX | quanterix corp | 5.04 | 957,747 | 6,369,020 | added | 157 | ||
AKYA | akoya biosciences inc | 4.83 | 4,697,780 | 6,107,120 | unchanged | 0.00 | ||